Bio-Rad Laboratories, Inc. (NYSE:BIO) is an interesting activist-investor target as it combines a substantial liquid asset position and an underperforming core business that could benefit from operational restructuring. While the stock has rallied 19% year-to-date, Elliott Investment Management insists it can generate more value. Explore why...